Originally developed for diabetes management and obesity treatment, these medications exhibit promising anti-inflammatory properties that could help manage UC symptoms
In the meantime, Kumar says for those on them long term, transitioning on and off the drugs will be a reality many patients will face, if nothing else, because of other medical situations they may run into, such as a surgery or pregnancy
and monitor them on a regular basis
Respuesta Rpida: Las reacciones cutneas con semaglutida incluyen principalmente reacciones locales en el sitio de inyeccin (enrojecimiento, picazn, hinchazn) que afectan al 1-5% de los pacientes, y ocasionalmente erupciones generalizadas o urticaria
EARLY ACCESS Be the first to book new treatments, services, and limited-time offers
Both were targeted on the Spanish patients by using the clinical data from the SUSTAIN 2 trial, which included type 2 diabetes patients ( 18 years) inadequately controlled (HbA1c 7.0-10.5%) despite stable treatment with metformin, thiazolidinediones, or both, with female proportion of semaglutide population being 50%, mean age being 55.42 years, mean diabetes duration being 6.52 years, and mean HbA1c being 8.0% [5]
